Basics EyePoint Pharmaceuticals, Inc. Common Stock IPO Date: February 1, 2005 Sector: Healthcare Industry: Pharma Market Cap: $1.32B Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 3.75% Avg Daily Range (30 D): $0.51 | 3.08% Avg Daily Range (90 D): $0.44 | 3.10% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): .91M Avg Daily Volume (90 D): 1.01M Trade Size Avg Trade Size (Sh.): 119 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 70 Institutional Trades Total Inst.Trades: 887 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.98M Avg Inst. Trade (90 D): $1.68M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.64M Avg Closing Trade (30 D): $3.11M Avg Closing Trade (90 D): $2.13M Avg Closing Volume: 126.33K     News Jan 7, 2026 @ 12:00 PM EyePoint Reports Corporate Update and Anticipated ... Source: Eyepoint, Inc. Nov 19, 2025 @ 12:00 PM EyePoint Announces Positive Recommendation from In... Source: Eyepoint Pharmaceuticals Nov 5, 2025 @ 12:00 PM EyePoint Reports Third Quarter 2025 Financial Resu... Source: Eyepoint Pharmaceuticals Oct 15, 2025 @ 2:43 AM EyePoint Announces Pricing of Public Offering Source: Eyepoint Pharmaceuticals, Inc. Aug 26, 2025 @ 11:00 AM EyePoint Announces Participation at Upcoming Inves... Source: Eyepoint Pharmaceuticals, Inc. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3 $-.85 $-.85 Diluted EPS $-3 $-.85 $-.85 Revenue $ 42.34M $ .97M $ 5.33M Gross Profit $ $ $ Net Income / Loss $ -205.75M $ -59.73M $ -59.43M Operating Income / Loss $ -218.33M $ -62.03M $ -62.23M Cost of Revenue $ $ $ Net Cash Flow $ -5.25M $ 3.43M $ -14.02M PE Ratio     Splits Dec 09, 2020:   1:10 Jun 11, 2008:   1:4